Position
BARCLAYS PLC in Sutro Biopharma, Inc.
Back to the book · All holders of STRO
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $3.34K$0.87 → $24.91
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2022 | 81.9K | $661.7K | — | — | — | 0.0% |
| Q1 2023 | 121.1K | $559.7K | $4.62 | −$283.4K | $181.3K | 0.0% |
| Q2 2023 | 44.5K | $206.9K | $4.65 | $1.33K | −$354.2K | 0.0% |
| Q3 2023 | 62.6K | $217.1K | $3.47 | −$52.5K | $62.8K | 0.0% |
| Q4 2023 | 132.1K | $566.5K | $4.29 | $51.3K | $298.1K | 0.0% |
| Q1 2024 | 79.7K | $450.5K | $5.65 | $108.4K | −$224.5K | 0.0% |
| Q2 2024 | 56.3K | $164.8K | $2.93 | −$153K | −$132.6K | 0.0% |
| Q3 2024 | 273K | $944.6K | $3.46 | $29.8K | $750K | 0.0% |
| Q4 2024 | 158.8K | $292.2K | $1.84 | −$257.3K | −$395.1K | 0.0% |
| Q1 2025 | 116.3K | $75.7K | $0.65 | −$138.3K | −$78.3K | 0.0% |
| Q2 2025 | 6.62K | $4.72K | $0.71 | $419 | −$71.4K | 0.0% |
| Q3 2025 | 2.77K | $2.4K | $0.87 | $427 | −$2.75K | 0.0% |
| Q1 2026 | 139 | $3.46K | $24.91 | $3.34K | −$2.28K | 0.0% |